Blood eosinophil phenotype during treatment with mepolizumab in patients with severe eosinophilic asthma
Allergology International · 2024
DOI: 10.1016/j.alit.2024.03.005 ↗Kurz gefasst
Leserbrief in der Zeitschrift Allergology International, 2024. Verfasst von Chio Sakai und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pulmonary Medicine, Faculty of Medicine, University of Tsukuba, Ibaraki, Japan. Hauptthemen laut MEDLINE: Antibodies, Monoclonal, Humanized, Asthma, Eosinophils, Phenotype. Die Arbeit nennt 9 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: GSK, GlaxoSmithKline Japan.
Abstract (Originalsprache)
This study was funded by GlaxoSmithKline in their investigator sponsored studies (ISS) scheme (Study ID 213388).
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Pulmonary Medicine, Faculty of Medicine, University of Tsukuba, Ibaraki, Japan.
- Department of Pulmonary Medicine, Faculty of Medicine, University of Tsukuba, Ibaraki, Japan. Electronic address: mmatsuyama@md.tsukuba.ac.jp.
- Department of Genome Biology, Faculty of Medicine, University of Tsukuba, Ibaraki, Japan.
Förderung
- GSK
- GlaxoSmithKline Japan
Zitieren
APA
Sakai, C., Matsuyama, M., Nakajima, M., Matsumura, S., Nonaka, M., Arai, N., Kuramoto, K., Yoshida, K., Morishima, Y., Muratani, M., & Hizawa, N. (2024). Blood eosinophil phenotype during treatment with mepolizumab in patients with severe eosinophilic asthma. Allergology International. https://doi.org/10.1016/j.alit.2024.03.005
Vancouver
Sakai C, Matsuyama M, Nakajima M, Matsumura S, Nonaka M, Arai N, et al. Blood eosinophil phenotype during treatment with mepolizumab in patients with severe eosinophilic asthma. Allergology International. 2024. doi:10.1016/j.alit.2024.03.005
BibTeX
@article{Sakai2024,
author = {Sakai, Chio and Matsuyama, Masashi and Nakajima, Masayuki and Matsumura, Sosuke and Nonaka, Mizu and Arai, Naoki and Kuramoto, Kenya and Yoshida, Kazufumi and Morishima, Yuko and Muratani, Masafumi and Hizawa, Nobuyuki},
title = {Blood eosinophil phenotype during treatment with mepolizumab in patients with severe eosinophilic asthma},
journal = {Allergology International},
year = {2024},
doi = {10.1016/j.alit.2024.03.005}
}
EUVIMED